Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.0%

4 terminated out of 50 trials

Success Rate

82.6%

-3.9% vs benchmark

Late-Stage Pipeline

8%

4 trials in Phase 3/4

Results Transparency

21%

4 of 19 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (21)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (2)

Trial Status

Completed19
Unknown13
Recruiting7
Not Yet Recruiting4
Terminated4
Active Not Recruiting3

Trial Success Rate

82.6%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT06489535Not ApplicableActive Not Recruiting

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

NCT03226158Active Not RecruitingPrimary

Next Generation Pathogen Sequencing for Prediction of Adverse Events

NCT07491419Not ApplicableRecruitingPrimary

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

NCT06069206Not ApplicableCompletedPrimary

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT07407673Phase 2Not Yet Recruiting

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

NCT07372131Not ApplicableRecruitingPrimary

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

NCT05210439Phase 4Active Not RecruitingPrimary

Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

NCT07175116Not ApplicableRecruiting

Advanced Dressings for CVC Infection Prevention in PICU

NCT06531031Not Yet RecruitingPrimary

Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples

NCT07082322Not Yet RecruitingPrimary

European Prospective Bloodstream Infection Cohort

NCT06174649Not ApplicableCompleted

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial

NCT07004049Phase 4RecruitingPrimary

Optimising TREATment for Severe Gram-Negative Bacterial Infections

NCT06576258Not ApplicableRecruitingPrimary

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

NCT06624618Recruiting

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

NCT06271031Recruiting

Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection

NCT05210387Not ApplicableTerminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

NCT05411315Not ApplicableCompleted

Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment

NCT05270135Not ApplicableCompleted

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

NCT06160115Unknown

The Role of NK Cells to Detect Blood Infection in ALL.

NCT00870623CompletedPrimary

Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections

Scroll to load more

Research Network

Activity Timeline